ISSN 2097-5724 CN 61-1535/R 主管·主办:陕西省疾病预防控制中心
疾病预防与控制 Disease Prevention and Control 医学学术期刊 双月刊
2026-04-042 检验与方法 2026, 2(04): 165-168

核酸检测质量监测指标评价与无效结果成因分析

徐州市红十字血液中心 2.徐州医科大学附属医院

14下载次数 0被引频次 29阅读次数 7参考文献
知网阅读全文
摘要

目的 回顾性分析无偿献血者核酸检测(NAT)结果,评估NAT质量监测指标并探讨无效结果成因,为提升NAT检测质量提供科学依据。方法 收集2023年1月1日至2024年12月31日期间的201186例无偿献血者NAT的资料。计算NAT不合格率、NAT拆分反应率、NAT无效批次率和试剂使用率。同时和国家临床检验中心发布的数据进行比较和分析。结果 2023-2024年NAT不合格率均值为0.06%,各季度差异无统计学意义(P>0.05),且各季度均不高于全国同组试剂平均水平。NAT拆分反应率均值为47.20%,各季度差异无统计学意义(P>0.05),且有4个季度低于全国同组试剂平均水平。NAT无效批次率均值为2.14%,各季度差异无统计学意义(P>0.05),且有6个季度高于全国同组试剂平均水平。NAT试剂使用率均值为144.49%,各季度差异有统计学意义(P<0.05),且有6个季度高于全国同组试剂平均水平。设备故障和对照无效是NAT结果无效的两大主要原因,分别占NAT无效结果总数的46.52%和38.37%。结论 历年NAT质量指标趋势及全国数据对标表明,监测指标可反映核酸检测全过程、预警风险并优化质控体系;设备故障、对照失效造成结果无效,为实验室亟待解决的难题。

Abstract

Objective To systematically evaluate nucleic acid testing(NAT) quality monitoring indicators and thoroughly investigate the causes of invalid results and provide a scientific basis for improving nucleic acid testing(NAT) testing quality by retrospectively analyzing NAT results from voluntary blood donors. Methods We collected data from 201,186 voluntary blood donors tested between January 1, 2023, and December 31, 2024 at the Xuzhou Red Cross Blood. We calculated the following parameters: NAT reactive rate, NAT resolution reactive rate, NAT invalid batch rate, and reagent utilization rate, and compared them with data published by the National Center for Clinical Laboratories. Results From 2023 to 2024, the average NAT reactive rate was 0.06%, with no statistically significant differences across quarters(P>0.05), and all quarterly NAT reactive rates were not higher than the national average for the same reagent group. The average NAT resolution reactive rate was 47.20%, showing no significant differences across quarters(P>0.05), and four quarters exhibited rates below the national average for the same reagent group. The average NAT invalid batch rate reached 2.14%, without statistically significant differences across quarters(P>0.05), and six quarters recorded rates higher than the national benchmark for the same reagent group. The average reagent utilization rate was 144.49%, demonstrating statistically significant differences across quarters(P<0.05), and six quarters exceeded the national average for the same reagent group. Equipment failure and invalid controls were the two primary reasons for NAT invalid results, accounting for 46.52% and 38.37% respectively. Conclusion The trend analysis of annual NAT quality indicators and comparison with national data show that monitoring indicators can reflect the whole process of nucleic acid testing, alert potential risks and optimize the quality control system. Invalid test results caused by equipment failures and failed controls remain urgent problems to be solved in laboratories.

引用本文

按标准格式复制,或导出到文献管理软件
[1]钱露,张帅.核酸检测质量监测指标评价与无效结果成因分析[J].疾病预防与控制,2026,2(04):165-168.